The Safety and Efficacy of an NAD+ Boosting Product Together With a Low Carbohydrate Diet in Adults With Mild Hypertension and Eligible for Normal-standard-of-care
Clinical trial NCT05298410 · COMPLETED
Trial details
- NCT number
- NCT05298410
- Sponsor
- Limitless Research Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-17
- Primary completion
- 2022-09-28
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.